Jentashapir Journal of Health Research

Published by: Kowsar

Prevalence of Skin Cancer in Isfahan Province, Iran

Zahra Tolou-Ghamari 1 , *
Author Information
1 Isfahan Kidney Transplantation Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • Jentashapir Journal of Health Research: April 2018, 9 (2); e82743
  • Published Online: August 29, 2018
  • Article Type: Research Article
  • Received: July 30, 2018
  • Accepted: August 12, 2018
  • DOI: 10.5812/jjhr.82743

To Cite: Tolou-Ghamari Z. Prevalence of Skin Cancer in Isfahan Province, Iran, Jentashapir J Health Res. 2018 ; 9(2):e82743. doi: 10.5812/jjhr.82743.

Abstract
Copyright © 2018, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Eisemann N, Waldmann A, Holleczek B, Katalinic A. Observed and expected mortality in the German skin cancer screening pilot project SCREEN. J Med Screen. 2018;25(3):166-8. doi: 10.1177/0969141317734003. [PubMed: 29169295].
  • 2. Cakir BO, Adamson P, Cingi C. Epidemiology and economic burden of nonmelanoma skin cancer. Facial Plast Surg Clin North Am. 2012;20(4):419-22. doi: 10.1016/j.fsc.2012.07.004. [PubMed: 23084294].
  • 3. Gallagher RP, Lee TK, Bajdik CD, Borugian M. Ultraviolet radiation. Chronic Dis Can. 2010;29 Suppl 1:51-68. [PubMed: 21199599].
  • 4. Bijlsma MF, Roelink H. Skin-derived vitamin D3 protects against basal cell carcinoma. J Invest Dermatol. 2017;137(12):2469-71. doi: 10.1016/j.jid.2017.07.816. [PubMed: 29169462].
  • 5. Chen ST, Li X, Han J. Personal history of non-melanoma skin cancer diagnosis and death from melanoma in women. Int J Cancer. 2018;142(8):1536-41. doi: 10.1002/ijc.31176. [PubMed: 29171018].
  • 6. Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ. Proton therapy for head and neck cancers. Semin Radiat Oncol. 2018;28(1):53-63. doi: 10.1016/j.semradonc.2017.08.004. [PubMed: 29173756].
  • 7. Jobeili L, Rousselle P, Beal D, Blouin E, Roussel AM, Damour O, et al. Selenium preserves keratinocyte stemness and delays senescence by maintaining epidermal adhesion. Aging (Albany NY). 2017;9(11):2302-15. doi: 10.18632/aging.101322. [PubMed: 29176034]. [PubMed Central: PMC5723688].
  • 8. Sturgeon A, Pate DA, Patel R, Snodgrass K, Tarbox M, Prabhu F, et al. Incidence of non-melanoma skin cancer in the Uninsured. J Health Care Poor Underserved. 2017;28(4):1327-32. doi: 10.1353/hpu.2017.0117. [PubMed: 29176098].
  • 9. G. B. D. Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345-422. doi: 10.1016/S0140-6736(17)32366-8. [PubMed: 28919119]. [PubMed Central: PMC5614451].
  • 10. Baldwin J, Janitz AE, Erb-Alvarez J, Snider C, Campbell JE. Prevalence and mortality of melanoma in Oklahoma among racial groups, 2000 - 2008. J Okla State Med Assoc. 2016;109(7-8):311-6. [PubMed: 27885301]. [PubMed Central: PMC5119754].
  • 11. Reichrath J. The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer? Prog Biophys Mol Biol. 2006;92(1):9-16. doi: 10.1016/j.pbiomolbio.2006.02.010. [PubMed: 16603232].
  • 12. Wang DM, Morgan FC, Besaw RJ, Schmults CD. An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015. J Am Acad Dermatol. 2018;78(1):47-53. doi: 10.1016/j.jaad.2017.09.031. [PubMed: 28947293].
  • 13. Razi S, Enayatrad M, Mohammadian-Hafshejani A, Salehiniya H, Fathali-Loy-Dizaji M, Soltani S. The epidemiology of skin cancer and its trend in Iran. Int J Prev Med. 2015;6:64. doi: 10.4103/2008-7802.161074. [PubMed: 26288708]. [PubMed Central: PMC4521305].
  • 14. Razi S, Rafiemanesh H, Ghoncheh M, Khani Y, Salehiniya H. Changing trends of types of skin cancer in Iran. Asian Pac J Cancer Prev. 2015;16(12):4955-8. [PubMed: 26163621].
  • 15. Apalla Z, Sotiriou E, Lallas A, Lazaridou E, Vakirlis E, Ioannides D. Basal cell carcinoma in a childhood cancer survivor: What neurosurgeons should avoid. Skin Appendage Disord. 2017;3(4):202-4. doi: 10.1159/000476070. [PubMed: 29177149]. [PubMed Central: PMC5697514].
  • 16. Tolou Ghamari Z. Prevalence of lung cancer in Isfahan province, Iran. J Egypt Natl Canc Inst. 2018;30(2):57-9. doi: 10.1016/j.jnci.2018.03.001. [PubMed: 29691096].
  • 17. Tolou-Ghamari Z, Palizban AA, Michael Tredger J. Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay. Drugs R D. 2004;5(1):17-22. [PubMed: 14725486].
  • 18. Horsham C, Auster J, Sendall MC, Stoneham M, Youl P, Crane P, et al. Interventions to decrease skin cancer risk in outdoor workers: update to a 2007 systematic review. BMC Res Notes. 2014;7:10. doi: 10.1186/1756-0500-7-10. [PubMed: 24397996]. [PubMed Central: PMC4028889].
  • 19. Thieu K, Ruiz ME, Owens DM. Cells of origin and tumor-initiating cells for nonmelanoma skin cancers. Cancer Lett. 2013;338(1):82-8. doi: 10.1016/j.canlet.2012.05.008. [PubMed: 22579650]. [PubMed Central: PMC3422447].
  • 20. Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev. 2015;16(4):1409-13. [PubMed: 25743807].
  • 21. Noorbala MT, Kafaie P. Analysis of 15 years of skin cancer in central Iran (Yazd). Dermatol Online J. 2007;13(4):1. [PubMed: 18318998].
  • 22. Carucci JA, Leffell DJ. Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis. Arch Dermatol. 2000;136(11):1415-6. [PubMed: 11074712].
  • 23. Asilian AE. [Skin cancer evaluation in center of Iran]. Pajoohesh Med Sci J. 1998;2:65-7. Persian.
  • 24. Tolou-Ghamari Z, Najafi MR, Mehavari Habibabadi J, Zare M. Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics. Int J Prev Med. 2013;4(Suppl 2):S343-S346. [PubMed: 23776749]. [PubMed Central: PMC3678243].
  • 25. Shaygannejad V, Rezaei Dehnavi S, Ashtari F, Karimi S, Dehghani L, Meamar R, et al. Study of Type A and B Behavior Patterns in Patients with Multiple Sclerosis in an Iranian Population. Int J Prev Med. 2013;4(Suppl2):S279-S283. [PubMed: 23776738]. [PubMed Central: PMC3678232].
  • 26. Tolou-Ghamari Z, Palizban AA. Laboratory Monitoring of Cyclosporine Pre-dose Concentration (C0) After Kidney Transplantation in Isfahan. Iran J Med Sci. 2015;28(2):81-85.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments